Sylwia Olejniczak
Warsaw, MZ 02089, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.
Journal: Journal of medicinal chemistry
Published: May 06, 2026
Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1.
Journal: Journal of medicinal chemistry
Published: March 01, 2024
Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis.
Journal: Journal of medicinal chemistry
Published: October 20, 2020
A New Inhibitor of Tubulin Polymerization Kills Multiple Cancer Cell Types and Reveals p21-Mediated Mechanism Determining Cell Death after Mitotic Catastrophe.
Journal: Cancers
Published: July 13, 2020
Benzoxazepine-Derived Selective, Orally Bioavailable Inhibitor of Human Acidic Mammalian Chitinase.
Journal: ACS medicinal chemistry letters
Published: February 21, 2020
Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases.
Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases.
Journal: Journal of medicinal chemistry
Published: July 11, 2019
Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.
Journal: Journal of medicinal chemistry
Published: December 29, 2017
Discovery of selective, orally bioavailable inhibitor of mouse chitotriosidase.
Journal: Bioorganic & medicinal chemistry letters
Published: September 16, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026